Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2187-2194

  Al Saif, Osama ^a   Farrar, William B ^a   Bloomston, Mark ^a   Porter, Kyle ^b   Ringel, Matthew D ^a   Kloos, Richard T ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CERVICAL LYMPH NODE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; ADOLESCENT; CANCER STAGING; LYMPH NODE; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; SECOND LOOK SURGERY; STATISTICS; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; REOPERATION; RETROSPECTIVE STUDIES; SECOND-LOOK SURGERY; THYROID NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952764723     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0063     Document Type: Article

References (23)

1. Jossart GH, Clark OH 1994 Well-differentiated thyroid cancer. Curr Probl Surg 31:933-1012
2. Schlumberger MJ 1998 Medical progress - papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
3. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648
4. Kloos RT 2005 Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 6:323-338 (Pubitemid 41223386)
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
6. Kloos RT, Mazzaferri EL 2005 A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90:5047-5057
7. Mazzaferri EL, Kloos RT 2002 Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490-1498
8. Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, Reading CC, Charboneau JW 2006 Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489-494; discussion 494-496
9. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
10. Alzahrani AS, Raef H, Sultan A, Al Sobhi S, Ingemansson S, Ahmed M, Al Mahfouz A 2002 Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. J Endocrinol Invest 25:526-531
11. Binyousef HM, Alzahrani AS, Al-Sobhi SS, Al SH, Chaudhari MA, Raef HM 2004 Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer. World J Surg 28:1110-1114
12. Davila-Cervantes A, Gamino R, Gonzalez O, Herrera MF 2003 Surgical treatment of recurrent differentiated thyroid carcinoma. Eur J Surg Suppl 14-17 (Pubitemid 36918751)
13. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI 2009 Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31:1152-1163
14. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI 2008 Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118:768-775
15. Grebe SK, Hay ID 1996 Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43-63 (Pubitemid 26047382)
16. Grant CS, Hay D 1988 Local recurrence of papillary thyroid carcinoma after unilateral or bilateral thyroidectomy. Wien Klin Wochenschr 100:342-336
17. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
18. Sherman SI, Angelos P, Ball DW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson Jr JA, Ridge JA, Shah JP, Sisson JC, Tuttle RM, Urist MM 2007 Thyroid carcinoma. J Natl Compr Canc Netw 5:568-621
19. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW 1991 Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 117:601-605
20. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM 2002 AJCC cancer staging manual. 6th ed. Chicago: Springer Verlag
21. Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely Jr PE, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, Grever M, Shah MH 2009 Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol 27:1675-1684
22. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP 1977 Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171-196
23. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS 2004 Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214-1216